Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by GENZYME
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
020057
CEREDASE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
020367
CEREZYME
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
020898
THYROGEN
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
020926
RENAGEL
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021179
RENAGEL
New Drug Application
Approval
New formulation
(S) Standard review drug
021673
CLOLAR
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
022127
RENVELA
New Drug Application
Approval
New formulation
(S) Standard review drug
022311
MOZOBIL
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
(V) Orphan drug
022318
RENVELA
New Drug Application
Approval
New formulation
(S) Standard review drug
075721
LEUPROLIDE ACETATE
Abbreviated New Drug Application
Approval
103948
CAMPATH
LEMTRADA
Biologic License Application
Approval
103979
FABRAZYME
Biologic License Application
Approval
125141
MYOZYME
Biologic License Application
Approval
125291
LUMIZYME
Biologic License Application
Approval
Back to Companies who have applied for FDA Drug Approval